Quick answers
- What is Leukotrap RC PL System?
- Leukotrap RC PL System is a brand name of CP2D/AS-3 anticoagulant and additive system, a prescription medicine. The FDA NDC Directory lists 1 Leukotrap RC PL System product in 1 strength and form.
- Who makes Leukotrap RC PL System?
- GVS TM Inc lists 1 of the 1 Leukotrap RC PL System products in the FDA NDC Directory.
- Is there a generic or store brand of Leukotrap RC PL System?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Leukotrap RC PL System product. Ask your pharmacist whether one is right for you.
- Has Leukotrap RC PL System been recalled?
- No recall linked to Leukotrap RC PL System products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Leukotrap RC PL System is
Each Leukotrap RC PL System product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
CP2D/AS-3 anticoagulant and additive system · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dextrose, unspecified form 3.57 g/70 mL solution (intravenous) | Leukotrap RC PL System | 3 products, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: CP2D/AS-3 anticoagulant and additive system →
FDA approval
No Drugs@FDA application is linked to these products.
Companies that list Leukotrap RC PL System
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Leukotrap RC PL System products.
- GVS TM Inc1 product
Recalls
No recall linked to Leukotrap RC PL System products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.